BioNTech IPO Falls in Trading Debut as Biotech IPO Wave Ebbs

(Bloomberg) -- BioNTech SE rose briefly and then fell in its trading debut after pricing its U.S. initial public offering below its target range as a wave of biotechnology listings recedes.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.